Archived Newsletters
-
11.12.25 -- Solutions To Achieve Your Next AAV Gene Therapy Milestone With Confidence In Every Batch
11/12/2025
11/12/25 Outsourced Pharma Newsletter
-
11.12.25 -- Redefining API Manufacturing Through Continuous Innovation
11/12/2025
11/12/25 Outsourced Pharma Newsletter
-
11.12.25 -- Makary Talks Faster Drug Reviews, 'Continuous Trials,' DTC Ads
11/12/2025
11/12/25 Outsourced Pharma Newsletter
-
11.11.25 -- DNA-To-IND In Record Time? The Blueprint For Accelerating Biologics
11/11/2025
11/11/25 Outsourced Pharma Newsletter
-
11.11.25 -- Better Delivery, Better Outcomes: Simplifying Dosing With Nanoforming
11/11/2025
11/11/25 Outsourced Pharma Newsletter
-
11.11.25 -- A (Partial) Vindication For Wuxi AppTec … And Global Outsourcing
11/11/2025
11/11/25 Outsourced Pharma Newsletter
-
11.10.25 -- Considerations For Realizing A Successful Combination Products Program
11/10/2025
11/10/25 Outsourced Pharma Newsletter
-
11.10.25 -- STREAM Edition: Supply Chain Due Diligence Before Acquiring Bio Assets
11/10/2025
11/10/25 Outsourced Pharma Newsletter
-
11.10.25 -- Cell & Gene Therapy Outsourcing's New Paradigm
11/10/2025
11/10/25 Outsourced Pharma Newsletter
-
11.08.25 -- Outsourced Pharma Best Of October
11/8/2025
11/08/25 Outsourced Pharma Newsletter